Tenax Therapeutics, Inc. (TENX)
10.70
+0.16
(+1.57%)
USD |
NASDAQ |
Jun 09, 16:00
10.70
0.00 (0.00%)
After-Hours: 16:03
Tenax Therapeutics SG&A Expense (Quarterly) : 5.034M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Exicure, Inc. | 1.291M |
| Century Therapeutics, Inc. | 6.579M |
| Absci Corp. | 9.058M |
| Celularity, Inc. | 15.06M |
| Cardio Diagnostics Holdings, Inc. | 1.652M |